Historical record - last NADAC effective date: 3/18/2015
This NDC is on FDA's drug shortage list (posted Feb 22, 2012)
Reported reason: Other
Product Information
LIDOCAINE HCL 2% SYRINGE is a generic product labeled by Hospira Inc., priced at $0.4706 per ML under NDC 00409132305. Its NADAC has been published 53 times since Mar 18, 2015.
FDA first approved this application on Sep 28, 1998. Its Orange Book therapeutic-equivalence code is AP.
Strength
20 mg/mL
Manufacturer
Hospira Inc.NDC
00409132305
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
3/18/2015
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040302FDA Approved
9/28/1998
TE Code
AP
On Market Since
12/9/2005
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 2% SYRINGE has been published 53 times since Mar 18, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4706 per ML |
|---|---|
| All-time high | $0.4706 (Mar 16, 2016) |
| All-time low | $0.4706 (Mar 18, 2015) |
| Median price | $0.4706 |
| Average price | $0.4706 |
| Largest weekly change | 0.0% (Mar 25, 2015) |
| Weeks tracked | 53 |
| Tracking since | Mar 18, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Mar 16, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 2% SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 2% SYRINGE, manufactured by Hospira Inc., is $0.4706 per ML (NDC 00409132305), effective Mar 16, 2016.
How has the price of LIDOCAINE HCL 2% SYRINGE changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 2% SYRINGE has held within roughly two percent of its current level. It has been tracked across 53 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 2% SYRINGE?
Since Mar 18, 2015, the NADAC for LIDOCAINE HCL 2% SYRINGE has ranged from a low of $0.4706 (Mar 18, 2015) to a high of $0.4706 (Mar 16, 2016), with a median of $0.4706 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 2% SYRINGE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 2% VIAL, is $0.0569 per ML — about 88% below LIDOCAINE HCL 2% SYRINGE.
Who manufactures LIDOCAINE HCL 2% SYRINGE?
LIDOCAINE HCL 2% SYRINGE (NDC 00409132305) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is LIDOCAINE HCL 2% SYRINGE in shortage?
Yes — NDC 00409132305 is currently listed in FDA's drug shortage database (posted Feb 22, 2012). Reported reason: Other.